期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
RNASEH2A在肝细胞癌中的表达及临床意义
1
作者 戴京京 周武碧 +2 位作者 王祥 张利利 刘满庆 《医药前沿》 2024年第18期9-11,共3页
目的:探究核糖核酸酶H2亚基A(RNASEH2A)在肝细胞癌(HCC)中的表达水平,分析其与临床检测指标的关系,从而进一步提高HCC的临床诊断水平。方法:收集南京医科大学附属淮安第一医院病理科2016—2017年诊断为HCC患者(未放化疗)的癌组织及癌旁... 目的:探究核糖核酸酶H2亚基A(RNASEH2A)在肝细胞癌(HCC)中的表达水平,分析其与临床检测指标的关系,从而进一步提高HCC的临床诊断水平。方法:收集南京医科大学附属淮安第一医院病理科2016—2017年诊断为HCC患者(未放化疗)的癌组织及癌旁组织。制作病理蜡块,切片并免疫组化分析RNASEH2A在HCC癌组织和癌旁组织中的表达水平。收集临床患者增殖相关分子MKI67的表达水平,并分析RNASEH2A与MKI67的表达关系,从而进一步说明RNASEH2A与增殖的相关性。检测腺苷通路分子CD39表达,并分析RNASEH2A与其表达的关系。通过生物信息数据库分析RNASEH2A在HCC癌组织和癌旁组织中的表达水平,分析表达差异,并进行生存分析。结果:生物信息分析结果显示,在HCC患者中,癌组织的RNASEH2A表达水平高于癌旁组织,差异有统计学意义(P<0.05)。癌组织的RNASEH2A高表达与不良预后密切相关(P<0.001)。免疫组化的结果显示,HCC组织的RNASEH2A高表达于癌旁组织,差异有统计学意义(P<0.05)。生物信息分析结果显示,RNASEH2A与MKI67和CD39呈正相关性(r=0.67、0.17;P<0.05)。结论:在HCC中,RNASEH2A可作为一种诊断及预后的标志物,进一步提高HCC的早期诊断和早期治疗。 展开更多
关键词 rnaseh2A 肝细胞癌 生物信息 诊断 预后
下载PDF
pWPXL-RNASEH2A-GFP,pWPXL-RNASEH2A和pWPXL-RNASEH2A-HA慢病毒表达载体的构建
2
作者 巩秀 刘爱芬 +1 位作者 吕秀芳 赵奉波 《南通大学学报(医学版)》 2015年第5期352-356,340,共6页
目的 :构建p WPXL-RNASEH2A-GFP,p WPXL-RNASEH2A和p WPXL-RNASEH2A-HA慢病毒过表达载体。方法:通过实时荧光定量PCR(quantitative real-time polymerase chain reaction,RT-PCR)技术扩增人RNASEH2A基因的蛋白编码区(coding domain sequ... 目的 :构建p WPXL-RNASEH2A-GFP,p WPXL-RNASEH2A和p WPXL-RNASEH2A-HA慢病毒过表达载体。方法:通过实时荧光定量PCR(quantitative real-time polymerase chain reaction,RT-PCR)技术扩增人RNASEH2A基因的蛋白编码区(coding domain sequence,CDS),将纯化的PCR产物连接到p WPXL慢病毒表达载体,将3种重组载体与包装质粒共同转染HEK293T细胞,收集病毒上清液;再次感染HEK293T细胞并收集细胞蛋白,通过Western Blot检测RNASEH2A蛋白的表达水平。结果 :Western Blot结果显示RNASEH2A抗体、GFP抗体和HA抗体均能检测到过表达的RNASEH2A或RNASEH2A融合蛋白。结论:成功构建了可用于哺乳动物细胞的p WPXL-RNASEH2A,p WPXL-RNASEH2AGFP和p WPXL-RNASEH2A-HA慢病毒表达载体。 展开更多
关键词 rnaseh2A 绿色荧光蛋白 血细胞凝集素序列 融合蛋白
下载PDF
Inhibition of RNaseH2A Induces Fas-Regulated Programmed Cell Death in Hepatoma Cells
3
作者 Xiaowei Chang Yu Cai +1 位作者 Pu Yan Wujun Li 《Proceedings of Anticancer Research》 2022年第3期53-62,共10页
Objective:To screen clinically significant potential drug targets in liver cancer and to study the function and potential molecular mechanisms of this target protein in the development of liver cancer.Methods:By using... Objective:To screen clinically significant potential drug targets in liver cancer and to study the function and potential molecular mechanisms of this target protein in the development of liver cancer.Methods:By using the clinical database GEPIAto find genes that are differentially expressed in liver cancer compared to normal tissues,we further screened the genes that are highly expressed in hepatocellular carcinoma and have clinical prognostic relevance.Heat maps were used to sort these genes according to their clinical prognostic relevance,so as to screen for the target gene of interest.The characteristics of target gene expression and clinical prognosis in hepatocellular carcinoma were studied.The target gene was knocked down through siRNA,and cell proliferation experiments and apoptosis experiments were used to verify the importance of the target gene in the occurrence and development of liver cancer.Finally,we elucidated the potential molecular mechanism of the target gene's function in liver cancer based on the mutual regulatory relationship between the target gene and key apoptosis genes.Results:1482 genes were significantly underexpressed in liver cancer,and 725 genes were significantly overexpressed in liver cancer,of which RNaseH2A was significantly overexpressed in liver cancer and had a significant clinical prognosis.Knockdown of RNaseH2A inhibited the proliferation of hepatocellular carcinoma cells and induced apoptosis.Knockdown of RNaseH2A induced the high expression of Fas,a key gene for apoptosis,and liver cancer usually features low expression of Fas.After hepatocellular carcinoma cells that were knocked down of RNaseH2A continued were subject to Fas knockdown,hepatocellular carcinoma cell proliferation and apoptosis returned to normal levels.Conclusion:The high expression of RNaseH2A regulates the low expression of Fas,a key gene for apoptosis,thereby inhibiting apoptosis,promoting cell proliferation,and participating in the development of liver cancer. 展开更多
关键词 Liver cancer rnaseh2A FAS Apoptosis
下载PDF
Phenotypic Variability in a Family with Aicardi-Goutières Syndrome Due to the Common A177T RNASEH2B Mutation
4
作者 Victoria Tüngler Franziska Schmidt +2 位作者 Steve Hieronimus Claudio Reyes-Velasco Min Ae Lee-Kirsch 《Case Reports in Clinical Medicine》 2014年第3期153-156,共4页
Aicardi-Goutières syndrome (AGS) is a rare inflammatory encephalopathy mimicking in utero acquired viral infection. Cardinal findings comprise leukodystrophy, basal ganglia calcifications and cerebral atrophy alo... Aicardi-Goutières syndrome (AGS) is a rare inflammatory encephalopathy mimicking in utero acquired viral infection. Cardinal findings comprise leukodystrophy, basal ganglia calcifications and cerebral atrophy along with cerebrospinal fluid lymphocytosis and elevated interferon-α. In the majority of cases AGS is inherited as an autosomal recessive trait and caused by mutations in six genes including RNASEH2A, RNASEH2B, RNASEH2C, TREX1, SAMHD1 and ADAR1, all of which encode enzymes acting on nucleic acid species. Most patients present with first neurological signs in early infancy and experience severe global developmental delay. Here, we report on the unusual divergent phenotype of two siblings who both carry the most frequent AGS causing p.A177T (c.529G > A) RNASEH2B mutation in the homozygous state. While one sibling showed a typical AGS presentation with early onset and severe statomotor and mental impairment, the older sibling was intellectually completely normal. She was only diagnosed because of mild spasticity of the legs and serological signs of autoimmunity. These findings highlight the phenotypic variability of AGS and suggest that AGS may be underdiagnosed among children with mild cerebral palsy. 展开更多
关键词 Aicardi-Goutières Syndrome rnaseh2B INTERFERON-Α AUTOIMMUNITY
下载PDF
RNASEH2C基因复合杂合变异所致艾卡迪综合征3型患儿1例的临床及遗传学分析
5
作者 刘娟 胡继红 +3 位作者 覃蓉 段雅琴 周洪涛 熊裕娟 《中华医学遗传学杂志》 CAS CSCD 2023年第1期81-86,共6页
目的探讨1例RNASEH2C基因变异所致Aicardi-Goutières综合征3型(AGS 3)患儿的临床特征与遗传学病因。方法选取2021年3月27日于湖南省儿童医院就诊的1例AGS3患儿为研究对象。对患儿及其父母进行家系全外显子组测序,并利用Sanger测序... 目的探讨1例RNASEH2C基因变异所致Aicardi-Goutières综合征3型(AGS 3)患儿的临床特征与遗传学病因。方法选取2021年3月27日于湖南省儿童医院就诊的1例AGS3患儿为研究对象。对患儿及其父母进行家系全外显子组测序,并利用Sanger测序对候选变异进行验证。对变异进行晶体结构模拟分析,并构建质粒进行蛋白表达。通过检索文献,总结AGS 3型的表型与遗传学特点。结果患儿RNASEH2C基因存在复合杂合变异c.494G>C(p.Ter165Ser)(父源)与c.434G>T(p.Arg145Leu)(母源),既往均未见报道。蛋白结构预测分析c.434G>T(p.Arg145Leu)变异可能破坏局部结构的稳定性,体外功能实验表明该变异将导致蛋白表达降低。c.494G>C(p.Ter165Ser)变异破坏了终止密码子,导致蛋白产物延长。结论本研究发现了两个RNASEH2C基因的新变异,进一步丰富了AGS 3型的表型与变异谱。 展开更多
关键词 Aicardi-Goutières综合征3型 rnaseh2C基因 终止密码子 新变异
原文传递
Aicardi-Goutières综合征4型1例临床和基因分析 被引量:3
6
作者 张晓莉 韩瑞 +3 位作者 李小丽 王丽君 陈豪 贾天明 《临床儿科杂志》 CAS CSCD 北大核心 2018年第2期134-137,共4页
目的探讨Aicardi-Goutières综合征(AGS)的临床、影像及遗传学特点。方法回顾分析1例AGS 4型患儿的临床资料及二代基因测序结果,并复习相关文献。结果患儿,女,5个月,临床表现为反复发热,精神运动发育落后,癫痫,小头畸形,痉挛状态。... 目的探讨Aicardi-Goutières综合征(AGS)的临床、影像及遗传学特点。方法回顾分析1例AGS 4型患儿的临床资料及二代基因测序结果,并复习相关文献。结果患儿,女,5个月,临床表现为反复发热,精神运动发育落后,癫痫,小头畸形,痉挛状态。脑脊液淋巴细胞增多;头颅磁共振成像示脑萎缩、脑白质异常;头颅CT示双侧基底节区及脑白质钙化。基因检测发现RNASEH2A基因存在c.199G>C、c.322C>T复合杂合突变;c.322C>T致病性已有文献报道,与AGS 4型相关;c.199 G>C致病性尚未见文献报道。结论首次报道我国RNASEH2A基因变异所致AGS。 展开更多
关键词 Aicardi-Goutières综合征 rnaseh2A基因 颅内钙化
下载PDF
恶性疟原虫核糖核酸酶H2基因的重组质粒构建及其原核表达 被引量:3
7
作者 杨尚明 何殿殿 李妍 《广东医学》 CAS CSCD 北大核心 2011年第5期579-581,共3页
目的构建恶性疟原虫(plasmodium falciparum,P.falciparum)核糖核酸酶H2(ribonuclease H2,RNase H2)编码基因的重组质粒并在E.coli中表达。方法应用PCR技术从P.falciparum 3D7 cDNA文库(MRA-297)扩增RNase H2编码基因片段,将其T-A克隆... 目的构建恶性疟原虫(plasmodium falciparum,P.falciparum)核糖核酸酶H2(ribonuclease H2,RNase H2)编码基因的重组质粒并在E.coli中表达。方法应用PCR技术从P.falciparum 3D7 cDNA文库(MRA-297)扩增RNase H2编码基因片段,将其T-A克隆和测序,并与GenBank公布预测P.falciparum 3D7RNase H2(登录号PFF1150w)的基因序列进行同源比对,再将目的基因插入至表达载体pET23b中进行表达。结果 RNase H2基因全长为867 bp,与GenBank公布的RNase H2基因的同源性为99%,表达的RNase H2蛋白的相对分子质量(Mr)为33 000。结论重组RNase H2能在E.coli中高效表达,为研究此蛋白在P.falciparum DNA复制中的作用奠定了基础。 展开更多
关键词 恶性疟原虫 rnaseh2 克隆 基因表达
下载PDF
Aicardi-Goutières综合征2例及文献复习 被引量:1
8
作者 蒋琼 曾兰 +4 位作者 朱会 王齐艳 罗泽民 孙春华 朱书瑶 《疑难病杂志》 CAS 2023年第4期432-433,共2页
报道2例Aicardi-Goutières综合征的临床资料,并进行文献复习。
关键词 Aicardi-Goutières综合征 TREX1基因 rnaseh2C基因 诊断 治疗
下载PDF
Antisense transcription regulates the expression of sense gene via alternative polyadenylation
9
作者 Ting Shen Huan Li +5 位作者 Yifan Song Jun Yao Miao Han Ming Yu Gang Wei Ting Ni 《Protein & Cell》 SCIE CAS CSCD 2018年第6期540-552,共13页
Natural antisense transcripts (NAT) and alternative polyadenylation (APA) of messenger RNA (mRNA) are important contributors of transcriptome complexity, each playing a critical role in multiple biological proce... Natural antisense transcripts (NAT) and alternative polyadenylation (APA) of messenger RNA (mRNA) are important contributors of transcriptome complexity, each playing a critical role in multiple biological processes. However, whether they have crosstalk and function collaboratively is unclear. We discovered that APA enriched in human sense-antisense (S-AS) gene pairs, and finally focused on RNASEH2C-KAT5 S-AS pair for further study. In cis but not in trans over-expression of the antisense KAT5 gene promoted the usage of distal polyA (pA) site in sense gene RNASEH2C, which generated longer 3' untranslated region (3'UTR) and produced less protein, accompanying with slowed cell growth. Mechanistically, elevated Pol II occupancy coupled with SRSF3 could explain the higher usage of distal pA site. Finally, NAT-mediated downregulation of sense gene's protein level in RNASEH2C.KAT5 pair was specific for human rather than mouse, which lacks the distal pA site of RNASEH2C. We provided the first evidence to support that certain gene affected phenotype may not by the protein of its own, but by affecting the expression of its overlapped gene through APA, implying an unexpected view for understanding the link between genotype and phenotype. 展开更多
关键词 natural antisense transcripts alternative polyadenyaltion 3'UTR rnaseh2C KAT5
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部